AMTARQ



Trademark Coverage

No Class Specified

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Owner

Glaxo Group Limited

Business in Brentford, Middlesex, GB

Owns 3785 trademarks

Timeline
  • Jan 06
    2014
    Abandonment Notice Mailed Express Abandonment
  • Jan 06
    2014
    Abandonment Express Mailed
  • Jan 03
    2014
    TEAS Express Abandonment Received
  • Sep 16
    2013
    Notification Of Letter Of Suspension E Mailed
  • Sep 16
    2013
    Letter Of Suspension E Mailed
  • Sep 16
    2013
    Suspension Letter Written
  • Sep 16
    2013
    Assigned To Examiner
  • Jul 08
    2013
    New Application Office Supplied Data Entered In TRAM
  • Jun 28
    2013
    New Application Entered In TRAM